These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11249680)

  • 1. DNA vaccines against tuberculosis.
    Lowrie DB
    Curr Opin Mol Ther; 1999 Feb; 1(1):30-3. PubMed ID: 11249680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
    Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
    Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
    Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.
    Mollenkopf HJ; Groine-Triebkorn D; Andersen P; Hess J; Kaufmann SH
    Vaccine; 2001 Jul; 19(28-29):4028-35. PubMed ID: 11427279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccine.
    Sarhan MA
    Saudi Med J; 2010 Jan; 31(1):9-13. PubMed ID: 20062891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium-specific human CD8 T cell responses.
    Klein MR; Fox A
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):379-89. PubMed ID: 11798136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of protective efficacy of two tuberculosis DNA vaccines by lung histopathological analysis].
    Wu X; Yao G; Wang Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Nov; 35(6):384-6. PubMed ID: 11840765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.
    Xing Z; Lichty BD
    Tuberculosis (Edinb); 2006; 86(3-4):211-7. PubMed ID: 16504584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of DNA vaccines tuberculosis].
    Wu X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Apr; 23(4):253-4. PubMed ID: 11778216
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis vaccines - an update.
    Andersen P
    Nat Rev Microbiol; 2007 Jul; 5(7):484-7. PubMed ID: 17571458
    [No Abstract]   [Full Text] [Related]  

  • 16. Current tuberculosis vaccine development.
    Young DB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S254-6. PubMed ID: 10875794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
    Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
    J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity.
    Derrick SC; Yang AL; Morris SL
    Vaccine; 2004 Dec; 23(6):780-8. PubMed ID: 15542202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.